Inotiv Expands Protein/Peptide Bioanalytical Capabilities With This Deal
February 2, 2024
CNBC
Contract research organization Inotiv Inc (NASDAQ: NOTV ) acquired Nashville, Tennessee-based Protypia Inc for $11 million .
Inotiv specializes in nonclinical and analytical drug discovery, development services, research models, and related products and services.
Protypia is a protein/peptide bioanalytical company offering high-quality, targeted tissue-based ... Full story available on Benzinga.com
SweepCast
Simplest Unusual Options Activity Platform for traders. SweepCast can be used for swing or day traders who are looking to get insights on where Smart money is flowing, sign up today.